Neurexis Therapeutics
PrivateLast Round
Grant
Sep 18, 2024
Total Funding Raised
$4.65M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Neurexis Therapeutics is a biotechnology company that develops neuroprotective peptide therapeutics for the prevention of brain damage following ischemic events such as stroke and cardiac arrest.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurexis Therapeutics Comparables
Compare Neurexis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astrocyte Pharmaceuticals Inc. | 83% | |
| Infensa Bioscience | 79% | |
| NoNO Inc. | 78% |
Neurexis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 18, 2024 | ||||
| Grant | Apr 18, 2023 | ||||
| Series A | Mar 7, 2022 | ||||
| Grant | Oct 13, 2021 | ||||
| Grant | Jun 18, 2020 | ||||
Seed | Apr 8, 2020 |
Key People
Founding team and executive leadership
Neurexis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Colorado Office of Economic Development and International Trade (OEDIT) | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
| VIC Technology Venture Development | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 36% MoM.
- Jul 29, 2026
Monthly visitors increased 132% MoM.
Neurexis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neurexis Therapeutics's valuation, stock price, and market status.
Is Neurexis Therapeutics a public or private company?
Neurexis Therapeutics is a private company.
What is the current stock price of Neurexis Therapeutics?
Neurexis Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Neurexis Therapeutics worth (valuation)?
Valuation information for Neurexis Therapeutics is not publicly available.
Can I buy Neurexis Therapeutics stock?
Neurexis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neurexis Therapeutics's last funding round?
Neurexis Therapeutics's most recent funding round was Grant on September 18, 2024.
Who are the main investors in Neurexis Therapeutics?
Key investors in Neurexis Therapeutics include VIC Technology Venture Development.
Will Neurexis Therapeutics IPO soon?
No public IPO plans have been announced for Neurexis Therapeutics.
How can I track Neurexis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neurexis Therapeutics's secondary market activity and sign up for updates.